Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NTRK1 | P04629 | 1/20 | 0.44 |
| ▸ | LTK | P29376 | 1/20 | 0.44 |
| ▸ | TYRO3 | Q06418 | 1/20 | 0.44 |
| ▸ | NTRK2 | Q16620 | 1/20 | 0.44 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.44 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5171083 | 0.77 | NTRK1 (0.33) | NTRK1LTKTYRO3NTRK2CLK4 | |
| SCHEMBL5174008 | 0.75 | NTRK1 (0.32) | NTRK1LTKTYRO3NTRK2CLK4 | |
| SCHEMBL20631050 | 0.75 | NTRK1 (0.36) | NTRK1LTKTYRO3NTRK2CLK4 | |
| SCHEMBL19117676 | 0.75 | NTRK1 (0.36) | NTRK1LTKTYRO3NTRK2CLK4 | |
| SCHEMBL5172320 | 0.75 | NTRK1 (0.33) | NTRK1LTKTYRO3NTRK2CLK4 | |
| SCHEMBL20674232 | 0.69 | BRD4 (0.45) | — | |
| SCHEMBL6050600 | 0.69 | KDM4E (0.43) | — | |
| SCHEMBL844706 | 0.67 | NTRK1 (0.43) | NTRK1LTKTYRO3NTRK2CLK4 | |
| SCHEMBL7288734 | 0.66 | KMT2A (0.42) | — | |
| SCHEMBL10739064 | 0.66 | PTGDR2 (0.36) | NTRK1LTKTYRO3NTRK2CLK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4272832-A2 | ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF | Lakewood Amedex, Inc. (US) | 2023-11-08 | — | — | EP | disclosed |
| US-20210139522-A1 | ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF | Lakewood Amedex, Inc. | 2021-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210139522-A1 | ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF | CFTR, ABCB11, CEL | NTRK1 4856/4885LTK 2611/4885TYRO3 1994/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.